| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial
|
Onundarson, Páll T
|
|
2015
|
2 |
6 |
p. e231-e240
nvt p.
|
artikel
|
| 2 |
Laboratory monitoring of warfarin in the era of direct oral anticoagulants
|
Lippi, Giuseppe
|
|
2015
|
2 |
6 |
p. e223-e224
nvt p.
|
artikel
|
| 3 |
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial
|
Omuro, Antonio
|
|
2015
|
2 |
6 |
p. e251-e259
nvt p.
|
artikel
|
| 4 |
Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study
|
Mahmood, Shameem
|
|
2015
|
2 |
6 |
p. e241-e250
nvt p.
|
artikel
|
| 5 |
Primary CNS lymphoma: in search of the evidence
|
Montserrat, Emili
|
|
2015
|
2 |
6 |
p. e227-e228
nvt p.
|
artikel
|
| 6 |
Prognostic models in myelodysplastic syndromes
|
Della Porta, Matteo Giovanni
|
|
2015
|
2 |
6 |
p. e229-e230
nvt p.
|
artikel
|
| 7 |
Systemic and localised light-chain amyloidosis: two diseases
|
Röcken, Christoph
|
|
2015
|
2 |
6 |
p. e225-e226
nvt p.
|
artikel
|
| 8 |
Thank you for saving my life
|
The Lancet Haematology,
|
|
2015
|
2 |
6 |
p. e222-
1 p.
|
artikel
|
| 9 |
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study
|
Valcárcel, David
|
|
2015
|
2 |
6 |
p. e260-e266
nvt p.
|
artikel
|
Tijdschrift beschrijving